Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report
BMC Infectious Diseases volume 16, Article number: 160 (2016)
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a mild encephalopathy caused by various pathological processes, but encephalopathy due to bacteria is rare.
We report the case of a 45-year-old Japanese woman who on receiving chemotherapy for advanced breast cancer developed an altered mental status and dysarthria soon after fever from infection of a subcutaneous implantable port. Staphylococcus aureus was detected in her blood cultures. Magnetic resonance imaging (MRI) revealed an ovoid lesion in the central portion of the splenium of the corpus callosum (SCC). Although hypotension was not observed, we diagnosed probable toxic shock syndrome (TSS) based on fever (temperature: >38.9 °C), altered mental status, erythema, desquamation, thrombocytopenia, liver dysfunction, and creatine phosphokinase elevation. We administered antimicrobial therapy and her neurological symptoms improved gradually. The lesion in the SCC completely disappeared on MRI 7 days after disease onset.
We diagnosed this case as MERS caused by S. aureus bacteremia with TSS. This is the first report of such a case, and we suggest that when a TSS patient presents with neurological symptoms, the possibility of MERS should be considered.
Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a mild encephalopathy caused by various pathological processes such as viral or bacterial infections, drugs, metabolic and electrolyte abnormalities, and trauma . It is characterized by neurological symptoms such as consciousness, vertigo, and seizure.
Several viruses (influenza virus, adenovirus, mumps virus, varicella zoster virus [2, 3], rotavirus , measles virus , and hepatitis A virus ) and bacteria (Escherichia coli , Legionella pneumophila , and Mycoplasma pneumoniae ) have been reported to cause MERS, but bacteria are rarely the cause [2, 3]. Staphylococcus aureus, especially, is a very rare cause of MERS, and only one such case has been reported so far . Moreover, there are no reports on MERS associated with toxic shock syndrome (TSS).
We encountered a case of MERS caused by S. aureus bacteremia with TSS and report our findings in this study.
A 45-year-old Japanese woman had undergone chemotherapy for advanced breast cancer (TNM Classification for Breast Cancer, T4N0M0; clinical Stage IIIb) for 2 years. She had a subcutaneous implantable port attached to her left subclavian vein and was receiving vinorelbine 11 days before admission. A second dose of vinorelbine was administered 4 days before admission. She developed fever following pain and swelling at the site of the implantable port 2 days before admission. She was suspected to have catheter-related bloodstream infection and thus admitted to our hospital. The implantable port was removed and piperacillin/tazobactam was administered at 4.5 g every 8 h. On hospital day 2, altered mental status and dysarthria were observed.
At the onset of neurological symptoms, her vital signs were as follows: blood pressure, 109/63 mmHg; pulse, 96 bpm; respiratory rate, 26 bpm; and temperature, 39.5 °C. The Glasgow Coma Scale score for consciousness was 13 (eye opening, 4; verbal response, 4; and best motor response, 5). No obvious paralysis was noted, although evaluation of neurological symptoms was difficult because of disorders of consciousness. Conjunctival hyperemia was noted. Except for the subclavian lesion at the site of the implantable port, no abnormalities of the skin, lung, heart, and abdomen were noted. The subclavian lesion was red and swollen. Laboratory test results were as follows: white blood cell count 400/mm3; hemoglobin, 9.9 g/dl; platelet, 6.2 × 104/mm3; blood urea nitrogen, 15 mg/dl; creatinine, 0.69 mg/dl; aspartate aminotransferase, 48 U/l; alanine aminotransferase, 26 U/l; lactate dehydrogenase, 353 U/l; creatine phosphokinase, 1859 U/l; serum sodium, 130 mEq/l; serum potassium, 3.3 mEq/l; and C-reactive protein, 13.5 mg/dl (Table 1). Head magnetic resonance imaging (MRI) revealed an ovoid high-intensity lesion in the central portion of the SCC on diffusion-weighted imaging (DWI, Fig. 1). Based on the MRI findings, septic embolus or cerebral infarction was considered because the neurological symptoms occurred suddenly following fever due to catheter-related bloodstream infection. On the same day, gram-positive cocci were detected in blood cultures. Therefore, on hospital day 2, piperacillin/tazobactam therapy was switched to cefepime and vancomycin. On hospital day 4, methicillin-sensitive S. aureus (MSSA) was detected in blood cultures. Nafcillin and oxacillin, the first treatment of choice for MSSA-related diseases of the central nervous system, are not available in Japan. Therefore, cefepime was administered at 2 g every 8 h.
The patient's altered mental status and dysarthria improved gradually. On hospital day 9, 7 days after disease onset, the ovoid lesion had completely disappeared on MRI (Fig. 2).
Conjunctival congestion and erythema developed on hospital days 2 and 3, respectively. Aspartate aminotransferase, alanine aminotransferase, and creatine phosphokinase levels were high at 137, 88, and 11,240 U/l on hospital days 8, 4, and 8, respectively. Soon erythema developed, and desquamation occurred 2 weeks after disease onset. In addition, isolated MSSA strains produced toxic shock syndrome toxin-1 (TSST-1). Although hypotension was not seen, probable TSS was diagnosed from fever (temperature, >38.9 °C), erythema, desquamation, creatine phosphokinase elevation, liver dysfunction, thrombocytopenia, and altered mental status [11, 12].
On hospital day 12, we switched from cefepime to vancomycin plus ceftriaxone because of drug eruption. On hospital day 15, we switched from vancomycin plus ceftriaxone to cefazolin at 2 g every 8 h, because due to the following reasons we concluded it was not necessary to consider cerebrospinal fluid (CSF) penetration by the antimicrobial agent: (i) CSF examination results were unremarkable and culture negative, (ii) abnormal findings on head MRI were due to MERS, and (iii) multiple organ injuries were due to TSS.
Figure 3 shows the clinical course post admission. Transesophageal echocardiography revealed no abnormalities. Moreover, septic emboli were not detected by enhanced computed tomography of the neck, chest, abdomen, and pelvis. We continued antibiotic therapy for 4 weeks after the blood cultures tested negative, i.e., after hospital day 4. At the 6-month follow up, no recurrence was noted.
We describe a rare case of MERS caused by S. aureus bacteremia with probable TSS. MERS is caused by various viruses, such as influenza, mumps, adenovirus, varicella, and zoster virus, but rarely by bacteria [7, 9]. Thus far, only one case of MERS caused by S. aureus has been reported . To the best of our knowledge, this is the first reported case of MERS with TSS.
MRI is useful for diagnosing MERS [1, 13] as MRI scans can reveal lesions in the SCC. In a case reported by Doherty et al., the lesion presented as reduced diffusion on DWI, had a low ADC value, and disappeared within a month. The radiological findings of our case were typical of MERS . Acute disseminated encephalomyelitis (ADEM) is suggested to be considered as a differential diagnosis of postinfection encephalopathy . In our case, the splenial lesion completely disappeared a week before clinical recovery, thus ruling out ADEM. Other differential diagnoses include ischemia, posterior reversible encephalopathy syndrome, diffuse axonal injury, multiple sclerosis, hydrocephalus, Marchiafava-Bignami disease, lymphoma, and extrapontine myelinolysis . All were excluded clinically.
Our patient had a catheter-related bloodstream infection caused by MSSA. Probable TSS was diagnosed as the case met all the diagnostic criteria except hypotension and gastrointestinal symptoms  (Table 2). TSS is characterized by multiple organ impairment due to S. aureus exotoxin . Staphylococcal exotoxins can activate several T cells at once, resulting in massive cytokine production . Activated T cells release interleukin (IL)-1, IL-2, tumor necrosis factor (TNF)-alpha, TNF-beta, and interferon-gamma in large amounts, resulting in TSS . Although the mechanism of MERS is unknown, Tada et al. postulated two possible mechanisms for the transiently decreased ADC value of the lesions, intramyelinic edema, and inflammatory infiltrate . We suppose that the inflammatory infiltrate caused by cytokine cascades of TSS are involved in the pathogenesis of MERS in our case.
Although MERS coexisting with TSS is extremely rare, staphylococcal exotoxins may cause MERS. Since our patient did not have hypotension, we could perform head MRI. Typically, TSS presents with hypotension and poor general conditions, hindering MRI. Thus, one cannot ignore MERS coexisting with TSS.
To conclude, we report the world's first case of MERS caused by S. aureus bacteremia with TSS, and suggest that when a patient with TSS presents neurological symptoms, MERS should be considered.
Availability of data and materials
All the data supporting our findings is contained within the manuscript.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Executive Editor of this journal.
Ethics approval and consent to participate
apparent diffusion coefficient
acute disseminated encephalomyelitis
clinically mild encephalitis/encephalopathy with a reversible splenial lesion
magnetic resonance imaging
methicillin-sensitive S. aureus
splenium of the corpus callosum
tumor necrosis factor
toxic shock syndrome
Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol. 2005;62:433–7.
Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–8.
Tani M, Natori S, Noda K, Fujishima K, Hattori N, Mizuno Y, Okuma Y. Isolated reversible splenial lesion in adult meningitis: a case report and review of the literature. Intern Med. 2007;46:1597–600.
Kobata R, Tsukahara H, Nakai A, Tanizawa A, Ishimori Y, Kawamura Y, Ushijima H, Mayumi M. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr. 2002;26:825–8.
Mito Y, Yoshida K, Kikuchi S. Measles encephalitis with peculiar MRI findings: report of two adult cases. Neurol Med. 2002;56:251–6 [In Japanese].
Ko SY, Kim BK, Kim DW, Kim JH, Choe WH, Seo HY, Kwon SY. Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy. Clin Mol Hepatol. 2014;20:398–401.
Ogura H, Takaoka M, Kishi M, Kimoto M, Shimazu T, Yoshioka T, Sugimoto H. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol. 1998;19:1144–5.
Morgan JC, Cavaliere R, Juel VC. Reversible corpus callosum lesion in legionnaires' disease. J Neurol Neurosurg Psychiatry. 2004;75:651–4.
Shibuya H, Osamura K, Hara K, Hisada T. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion due to Mycoplasma pneumoniae infection. Intern Med. 2012;51:1647–8.
Hong JM, Joo IS. A case of isolated and transient splenial lesion of the corpus callosum associated with disseminated Staphylococcus aureus infection. J Neurol Sci. 2006;250:156–8.
Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1997;46(RR-10):1–55.
Tofte RW, Williams DN. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA. 1981;246:2163–7.
Friese SA, Bitzer M, Freudenstein D, Voigt K, Küker W. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology. 2000;42:795–802.
Schlievert PM. Role of superantigens in human disease. J Infect Dis. 1993;167:997–1002.
Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis. 1989;11 Suppl 1:S263–9.
No funding was received.
The authors declare that they have no competing interests.
KK: Management of the case and redaction and correction of the manuscript. TK: Redaction, correction, and restructuring of the manuscript. YS, KM: Clinical management of the case and correction of the manuscript. MM: Manuscript correction and redaction of the comment of the illustrations. All authors have read and approved the final manuscript.
About this article
Cite this article
Kosami, K., Kenzaka, T., Sagara, Y. et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report. BMC Infect Dis 16, 160 (2016). https://doi.org/10.1186/s12879-016-1516-0